Search - tctmd.com

Displaying 141 - 160 of 179

Sort: Relevancy | Date

FDA Approves Lotus Edge, Ushering Third Device Into US Market

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

April 24, 2019

Disparities Seen in Uptake of DOACs for VTE

News Daily News

Disparities Seen in Uptake of DOACs for VTE

April 05, 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

News Conference News ACC 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

April 05, 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

News Conference News ACC 2019

Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO

Michael O'Riordan

April 01, 2019

Burned Out: Experts Recommend Institutional Interventions, Community Understanding to Increase Physician Well-being

News Conference News ACC 2019

Burned Out: Experts Recommend Institutional Interventions, Community Understanding to Increase Physician Well-being

Yael L. Maxwell

March 28, 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

March 26, 2019

Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have Been Learned

News Conference News EHRA 2019

Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have Been Learned

March 26, 2019

Streamlined Procedure Maintains Benefits of Cryoablation Over Drugs for Paroxysmal A-fib

News Conference News EHRA 2019

Streamlined Procedure Maintains Benefits of Cryoablation Over Drugs for Paroxysmal A-fib

March 20, 2019

Live From New Orleans: Days 2 and 3 at ACC 2019

News Opinion Editor's Corner ACC 2019

Live From New Orleans: Days 2 and 3 at ACC 2019

March 18, 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

March 17, 2019

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

News Conference News CRT 2019

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

Yael L. Maxwell

March 14, 2019

FDA Extends MitraClip Indication to Include Functional MR

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

March 14, 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

March 11, 2019

Yo-Yo Diets Linked to Poorer CV Health in Women

News Conference News

Yo-Yo Diets Linked to Poorer CV Health in Women

March 07, 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

March 06, 2019

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

March 01, 2019

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

News Daily News

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

February 27, 2019

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

News Daily News

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

February 22, 2019

Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes?

News Conference News ISC 2019

Should Pioglitazone Be Used More for Secondary Stroke Prevention in Prediabetes?

February 14, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.